Delivery Order SPE2DB22D3301-SPE2DB24FZ2FY

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer, a 750 mg/15 mL injectable medication. The $2,414.43 firm fixed-price delivery order has a completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of AmerisourceBergen Corporation, is for the delivery of Injectafer 750 mg/15 ml vials. The $5,276.30 fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 30, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,907.20 firm fixed-price delivery order is for the supply of Injectafer, a 750 mg/15 ml vial medication, with a period of performance through January 15, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,003.58 firm fixed-price delivery order is for the supply of Injectafer, a 750 mg/15 ml vial medication, with an ultimate completion date of October 11, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,709.14, is for the delivery of Injectafer 750 mg/15 ml vials and has a completion date of January 8, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Injectafer 750 mg/15 ml vials to the Defense Logistics Agency (DLA). The contract, valued at $8,202.55, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and is a delivery order with a completion date of November 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Injectafer 750 mg/15 ml vials. The contract has a firm fixed price of $3,217.98 and a period of performance through September 18, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, which provides a broad...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,270.04 Firm Fixed Price Delivery Order is for the supply of Injectafer 750 mg/15 ml vials, with an ultimate completion date of November 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the U.S. Department of Defense's Medical Supply Chain agency to Amerisourcebergen Drug Corp's Corporate Office division. The $49,762.01 firm fixed price delivery order is for the supply of Injectafer 750 mg/15 ml vial, 15 ml, a pharmaceutical product. The award has an ultimate completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the Defense...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Injectafer (750 mg/15 ml vial) pharmaceutical products. The contract has a ceiling value of $5,471.36 and a completion date of September 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2FY
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is for the delivery of Injectafer 750 mg/15 ml vial, a specialty pharmaceutical product. The $8,837.40 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several large Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, to provide a wide range of medical commodities and prescription drugs to support federal healthcare programs and facilities. This particular delivery order does not have a set-aside designation.

Generated 11/5/24, 9:19 AM